Dual trigger in normally-responding assisted reproductive technology patients increases the number of top-quality embryos

Creative Commons License

ŞÜKÜR Y. E., Ulubasoglu H., Ilhan F. C., BERKER B., SÖNMEZER M., ATABEKOĞLU C. S., ...Daha Fazla

CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM, cilt.47, sa.4, ss.300-305, 2020 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.5653/cerm.2020.03804
  • Dergi Adı: CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier
  • Sayfa Sayıları: ss.300-305
  • Anahtar Kelimeler: Assisted reproductive technology, Dual trigger, Final oocyte maturation, GnRH agonist, Normal response, FINAL OOCYTE MATURATION, HUMAN CHORIONIC-GONADOTROPIN, LUTEINIZING-HORMONE SURGE, GNRH AGONIST, IVF CYCLES, INDUCTION, HCG, STIMULATION, RISK
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: The feasibility of a gonadotropin-releasing hormone agonist (GnRHa) trigger in normal responders is still a matter of debate. The aim of this study was to compare the number of mature oocytes, the number of good-quality embryos, and the live birth rate in normal responders triggered by GnRHa alone, GnRHa and human chorionic gonadotropin (hCG; a dual trigger), and hCG alone.